Search Results - "Scott, Lesley"

Refine Results
  1. 1

    Givosiran: First Approval by Scott, Lesley J.

    Published in Drugs (New York, N.Y.) (01-02-2020)
    “…Givosiran (Givlaari™) is an aminolevulinate synthase 1 (ALAS1)-directed small interfering RNA (siRNA) covalently linked to a ligand to enable specific delivery…”
    Get full text
    Journal Article
  2. 2

    Tocilizumab: A Review in Rheumatoid Arthritis by Scott, Lesley J.

    Published in Drugs (New York, N.Y.) (01-11-2017)
    “…Intravenous (IV) and subcutaneous (SC) tocilizumab (RoActemra ® ), an IL-6 receptor antagonist, are approved (± methotrexate) in numerous countries throughout…”
    Get full text
    Journal Article
  3. 3

    Niraparib: First Global Approval by Scott, Lesley J.

    Published in Drugs (New York, N.Y.) (01-06-2017)
    “…Oral niraparib, a highly-selective, potent poly(ADP-ribose) polymerase (PARP)-1 and PARP-2 inhibitor, is approved in the USA for the maintenance treatment of…”
    Get full text
    Journal Article
  4. 4

    Larotrectinib: First Global Approval by Scott, Lesley J.

    Published in Drugs (New York, N.Y.) (01-02-2019)
    “…Larotrectinib (VITRAKVI ® ) is an orally administered, small molecule, highly-selective, tropomyosin receptor kinase (TRK) inhibitor that was developed by Loxo…”
    Get full text
    Journal Article
  5. 5

    Apatinib: A Review in Advanced Gastric Cancer and Other Advanced Cancers by Scott, Lesley J.

    Published in Drugs (New York, N.Y.) (01-05-2018)
    “…Apatinib [Aitan ® (brand name in China)], also known as rivoceranib, is a novel, small molecule, selective vascular endothelial growth factor receptor-2…”
    Get full text
    Journal Article
  6. 6

    Ubrogepant: First Approval by Scott, Lesley J.

    Published in Drugs (New York, N.Y.) (01-02-2020)
    “…Ubrogepant (Ubrelvy™) is an orally administered, small molecule, highly-selective, calcitonin gene-related peptide (CGRP) antagonist that was developed by…”
    Get full text
    Journal Article
  7. 7

    Eravacycline: A Review in Complicated Intra-Abdominal Infections by Scott, Lesley J.

    Published in Drugs (New York, N.Y.) (01-02-2019)
    “…Eravacycline (Xerava™), a novel fully synthetic fluorocycline, consists of the tetracyclic core scaffold with unique modifications in the tetracyclic D ring;…”
    Get full text
    Journal Article
  8. 8

    Sitagliptin: A Review in Type 2 Diabetes by Scott, Lesley J.

    Published in Drugs (New York, N.Y.) (01-02-2017)
    “…The dipeptidyl peptidase-4 inhibitor sitagliptin (Januvia ® ; Glactiv ® ; Tesavel ® ; Xelevia™) is approved in more than 130 countries worldwide as monotherapy…”
    Get full text
    Journal Article
  9. 9

    Lemborexant: First Approval by Scott, Lesley J.

    Published in Drugs (New York, N.Y.) (01-03-2020)
    “…Lemborexant (DAYVIGO™) is an orally administered, dual orexin receptor (OXR) antagonist that exhibits reversible competitive antagonism at OXR1 and OXR2 (>…”
    Get full text
    Journal Article
  10. 10

    Rimegepant: First Approval by Scott, Lesley J.

    Published in Drugs (New York, N.Y.) (01-05-2020)
    “…The orally disintegrating tablet (ODT) formulation of rimegepant (NURTEC ODT ® ) is a small molecule, highly-selective, calcitonin gene-related peptide…”
    Get full text
    Journal Article
  11. 11

    Enzalutamide: A Review in Castration-Resistant Prostate Cancer by Scott, Lesley J.

    Published in Drugs (New York, N.Y.) (01-12-2018)
    “…Oral enzalutamide (Xtandi ® ), a second generation androgen receptor inhibitor, is indicated for the treatment of castration-resistant prostate cancer (CRPC)…”
    Get full text
    Journal Article
  12. 12

    Siponimod: A Review in Secondary Progressive Multiple Sclerosis by Scott, Lesley J.

    Published in CNS drugs (01-11-2020)
    “…Oral siponimod (Mayzent ® ), a next-generation, selective sphingosine 1-phosphate receptor (S1PR) 1 and 5 modulator, is approved in several countries for the…”
    Get full text
    Journal Article
  13. 13

    Lumasiran: First Approval by Scott, Lesley J., Keam, Susan J.

    Published in Drugs (New York, N.Y.) (01-02-2021)
    “…Lumasiran (Oxlumo™) is a subcutaneously administered small interfering RNA (siRNA) targeting the mRNA for hydroxyacid oxidase 1 gene ( HAO1 ; encodes glycolate…”
    Get full text
    Journal Article
  14. 14

    Alipogene Tiparvovec: A Review of Its Use in Adults with Familial Lipoprotein Lipase Deficiency by Scott, Lesley J.

    Published in Drugs (New York, N.Y.) (01-02-2015)
    “…Alipogene tiparvovec (Glybera ® ; AMT-011, AAV1-LPL S447X ) is an adeno-associated virus serotype 1-based gene therapy for adult patients with familial…”
    Get full text
    Journal Article
  15. 15

    Brexanolone: First Global Approval by Scott, Lesley J.

    Published in Drugs (New York, N.Y.) (01-05-2019)
    “…Brexanolone (ZULRESSO™) is an intravenously administered, small molecule, neuroactive steroid GABA A receptor positive allosteric modulator that was developed…”
    Get full text
    Journal Article
  16. 16

    Ferric Carboxymaltose: A Review in Iron Deficiency by Scott, Lesley J.

    Published in Drugs (New York, N.Y.) (01-03-2018)
    “…Intravenous ferric carboxymaltose (Ferinject ® ; Injectafer ® ) is a colloidal solution of nanoparticles which consist of a polynuclear iron…”
    Get full text
    Journal Article
  17. 17

    Dulaglutide: A Review in Type 2 Diabetes by Scott, Lesley J.

    Published in Drugs (New York, N.Y.) (01-02-2020)
    “…Subcutaneous dulaglutide (Trulicity ® ) is a once-weekly glucagon-like peptide-1 receptor agonist that is approved in numerous countries as an adjunct to diet…”
    Get full text
    Journal Article
  18. 18

    Dolutegravir/Lamivudine Single-Tablet Regimen: A Review in HIV-1 Infection by Scott, Lesley J.

    Published in Drugs (New York, N.Y.) (2020)
    “…The oral once-daily, fixed-dose single-tablet regimen (STR) of dolutegravir/lamivudine (Dovato ® ), combining a second generation integrase single-strand…”
    Get full text
    Journal Article
  19. 19

    Teriflunomide: A Review in Relapsing–Remitting Multiple Sclerosis by Scott, Lesley J.

    Published in Drugs (New York, N.Y.) (01-06-2019)
    “…Teriflunomide (Aubagio ® ) is a disease-modifying immunomodulatory drug with anti-inflammatory properties that selectively and reversibly inhibits the…”
    Get full text
    Journal Article
  20. 20

    Peramivir: A Review in Uncomplicated Influenza by Scott, Lesley J.

    Published in Drugs (New York, N.Y.) (01-09-2018)
    “…Intravenous peramivir (Alpivab™; Rapivab ® ; Rapiacta ® ; PeramiFlu ® ), the most recent globally approved inhibitor of influenza neuraminidase, is indicated…”
    Get full text
    Journal Article